Author： Pollock B.G.
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.4, 2001-04, pp. : 681-698
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Citalopram is a selective serotonin re-uptake inhibitor that has demonstrated antidepressant efficacy in numerous controlled clinical trials. Additional studies have shown that the drug benefits patients with other illnesses that are related in some way to serotonergic dysfunction, including anxiety, panic disorder, obsessive-compulsive disorder, premenstrual dysphoria, alcohol dependence and the behavioural disturbances of dementia. This paper reviews the full spectrum of citalopram’s clinical efficacy, as well as its safety and tolerability, in a range of patients.
Related content
Access to resources
Recommend
Sirolimus: a comprehensive review
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 11, 2001-11 ,pp. :
Atypical Depression: A Comprehensive Review
By Pae Chi-Un Tharwani Haresh Marks David M. Masand Prakash S. Patkar Ashwin A.
CNS Drugs, Vol. 23, Iss. 12, 2009-12 ,pp. :
Alitretinoin: a comprehensive review
By Cheng Caleb Michaels Jason Scheinfeld Noah
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. :